MetLife Investment Management’s Loxo Oncology, Inc LOXO Stock Holding History

MetLife Investment Management’s Portfolio LOXO Stock Details LOXO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-12,113	Closed	-$1.7M	–	2623
2018 Q4	$1.7M	Hold	12,113	–	–	0.02%	821
2018 Q3	$2.07M	Hold	12,113	–	–	0.02%	841
2018 Q2	$2.1M	Buy	12,113 +1,447	+14%	+$217K	0.02%	777
2018 Q1	$1.23M	Hold	10,666	–	–	0.01%	931
2017 Q4	$898K	Buy	+10,666	New	+$889K	0.01%	1067

Other funds holding LOXO

IUHSA

Itau Unibanco Holding S.A. Sao Paulo, Brazil $4.31B AUM 46.57% 1-Year Est. Return

MetLife Investment Management's LOXO Position: Q1 2019 in Review

MetLife Investment Management sold out of Loxo Oncology, Inc (LOXO) in Q1 2019, closing a stake of 12,113 shares — an estimated $1.7M sold.

MetLife Investment Management first reported a position in LOXO in Q4 2017 and held it in 5 quarters. The position peaked at $2.1M in Q2 2018. 1 fund tracked by Wall St. Rank holds LOXO as of Q1 2019.

MetLife Investment Management reported no remaining Loxo Oncology, Inc position as of Q1 2019 after selling out during the quarter.
MetLife Investment Management sold 12,113 Loxo Oncology, Inc shares in Q1 2019, an estimated $1.7M.
MetLife Investment Management first reported a position in Loxo Oncology, Inc in Q4 2017 and held it in 5 quarters.
MetLife Investment Management's Loxo Oncology, Inc position peaked at $2.1M in Q2 2018.
1 fund tracked by Wall St. Rank held Loxo Oncology, Inc as of Q1 2019.

Based on MetLife Investment Management's 13F filing for Q1 2019, filed 15 May 2019.